Camrelizumab, chemotherapy and apatinib in the neoadjuvant treatment of resectable oesophageal squamous cell carcinoma: a single-arm phase 2 trialResearch in context

Summary: Background: In resectable oesophageal squamous cell carcinoma (ESCC), the efficacy of camrelizumab combined with chemotherapy and apatinib followed by minimally invasive oesophagectomy is not clear. We aimed to fill this knowledge gap. Methods: This investigator-initiated, single-arm, pros...

Full description

Bibliographic Details

Main Authors:	Zixiang Wu, Chuanqiang Wu, Jing Zhao, Cong Wu, Haixian Peng, Qi Wang, Rui Bai, Xuefeng Fang, Hong He, Hong Shen, Ming Wu
Format:	Artigo
Language:	Inglês
Published:	Elsevier 2024-05-01
Series:	EClinicalMedicine
Subjects:	Oesophageal squamous cell carcinoma Neoadjuvant therapy Cancer immunotherapy Minimally invasive oesophagectomy
Online Access:	http://www.sciencedirect.com/science/article/pii/S2589537024001585
Tags:	Add Tag No Tags, Be the first to tag this record!